Delivery Order SPE2DB22D3009-SPE2DB24FAR67
- Not listed
- This federal contract award, valued at $1,569.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/mL vials, a pain management medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999.00. The IDC enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,299.44 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has a completion date of November 7, 2024 and was awarded on November 6, 2024. This award is a part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $3,180.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ketorolac 30mg/ml 25s, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,029.16, is a firm fixed-price delivery order contract with a completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, SPE2DB22D3004|SPE2DB25FPN57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,163.76, is for the delivery of Ketorolac 30 mg/ml vials, a pharmaceutical product used for pain management. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,066.91 firm fixed price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $1,408.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ketorolac 15 mg/ml vial, a medication used for pain management. The contract has an ultimate completion date of June 10, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $5,035.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ketorolac 30 mg/ml vial, a pain medication, to support military treatment facilities and other federal healthcare providers. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award, valued at $11,398.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566554030 - Ketorolac 30 mg/ml vials, a pain management medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB24FAR67Delivery Order
This federal contract award, valued at $1,711.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/mL vials, a pain management medication. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/8/24 |